未找到相关数据
P2Y12 Inhibitors and Quality of Life Outcomes in Critically Ill Patients Hospitalized for COVID-19: A Pre- Specified Secondary Analysis of the ACTIV4a Randomized Clinical Trial
被引：0
作者：
Wahid, Lana
Hade, Erinn M.
Cushman, Mary
Gong, Michelle N.
Renard, Valerie
Ko, Emily R.
Der, Tatyana
Kornblith, Lucy Z.
Lawler, Patrick R.
Reynolds, Harmony
机构：
来源：
关键词：
Quality of life;
Antiplatelet drugs;
Infection;
Outcomes;
Clinical trials;
D O I：
10.1161/circ.148.suppl_1.14153
中图分类号：
R5 [内科学];
学科分类号：
1002 ;
100201 ;
摘要：
A14153
引用
收藏
页数：3
相关论文